DOI: 10.1055/s-00000005

Aktuelle Rheumatologie

References

Yoo DH, Racewicz A, Brzezicki J. et al.
A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study.

Arthritis Res Ther 2016;
18: 82

Download Bibliographical Data

Access:
Access: